Endometrial carcinoma is the most common gynecological cancer in the United States, with an estimated incidence of over 40,000 cases per year. Endoscopic imaging is an important diagnostic tool for the evaluation of the uterus, but is typically limited to viewing the surface of the endometrium. Therefore, we propose to develop technology for depth resolved imaging of the endometrium. The innovation lies in a unique aperture-based imaging system, which obtains several photon migration paths in a single image, capture. Our Phase I effort is focused on development and validation of the depth-resolved imaging system in a phantom model. First, we will use Monte Carlo modeling to determine crucial design parameters. These results will then be used to create an aperture-based imaging prototype. Finally, a phantom model will be created and used to evaluate the endoscope's ability to probe a turbid medium. If we are successful, we envision a Phase II effort focused on the development and testing of a clinical grade prototype. It is our long-term goal to develop a tool, which, for the first time, would enable the gynecologist to evaluate and visualize submucosal lesions in an office setting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA108298-01
Application #
6788356
Study Section
Special Emphasis Panel (ZRG1-SSS-7 (11))
Program Officer
Baker, Houston
Project Start
2004-04-08
Project End
2006-03-31
Budget Start
2004-04-08
Budget End
2005-03-31
Support Year
1
Fiscal Year
2004
Total Cost
$238,444
Indirect Cost
Name
Infinite Biomedical Technologies, LLC
Department
Type
DUNS #
037376022
City
Baltimore
State
MD
Country
United States
Zip Code
21218